Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated June 29, 2023, reports on the Combined Ordinary and Extraordinary General Meeting held by Cellectis S.A. on June 27, 2023. The filing includes a press release and voting results from the meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes
Material changes reported relate to the composition of the Board of Directors:
- Mrs. Cécile Chartier was appointed as a director.
- The terms of office for Mr. Hervé Hoppenot and Mrs. Annick Schwebig ended immediately following the June 27, 2023 meeting.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The document serves primarily to disclose the meeting outcomes and board updates.
Key Facts for Investor Verification
- Confirmation of the new board composition following the June 27, 2023 meeting.
- Review of the attached press release (Exhibit 99.1) for any strategic announcements not detailed in the summary.
- Verification of voting results (Exhibit 99.2) regarding the board appointments and removals.